Chad vs Eritrea: Access to anti-retroviral drugs, female
Chad
72.0%
in 2024
Eritrea
72.0%
in 2024
Chad rank
76th
Eritrea rank
76th
Access to anti-retroviral drugs, female over time
- Chad
- Eritrea
How they compare
Chad currently reports 72.0% against 72.0% in Eritrea, a difference of 0.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Eritrea ahead.
Chad ranks 76th and Eritrea ranks 76th of 141 countries.
Across the 3 decades both report, Chad averaged higher in 1 and Eritrea in 2.
Head to head by decade
| Decade | Chad | Eritrea | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.0% | 4.9% | 0.1% | Chad |
| 2010s | 37.4% | 50.4% | 13.0% | Eritrea |
| 2020s | 62.8% | 71.2% | 8.4% | Eritrea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Chad or Eritrea?
- Chad, at 72.0% against 72.0% in Eritrea as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Chad and Eritrea?
- 0.0%, with Chad ahead.
- How many years of comparable data are there for Chad and Eritrea?
- 25 years are reported by both, from 2000 to 2024.
- How do Chad and Eritrea rank globally for access to anti-retroviral drugs, female?
- Chad ranks 76th and Eritrea ranks 76th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.